- Home
- UFI vs XBIT Comparison
UFI vs XBIT Comparison
Compare UFI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- XBIT
- Stock Information
- Founded
- UFI 1969
- XBIT 2005
- Country
- UFI United States
- XBIT United States
- Employees
- UFI N/A
- XBIT N/A
- Industry
- UFI Textiles
- XBIT Pharmaceuticals and Biotechnology
- Sector
- UFI Consumer Discretionary
- XBIT Health Care
- Exchange
- UFI Nasdaq
- XBIT Nasdaq
- Market Cap
- UFI 84.6M
- XBIT 82.3M
- IPO Year
- UFI N/A
- XBIT 2015
- Fundamental
- Price
- UFI $4.66
- XBIT $2.55
- Analyst Decision
- UFI
- XBIT
- Analyst Count
- UFI 0
- XBIT 0
- Target Price
- UFI N/A
- XBIT N/A
- AVG Volume (30 Days)
- UFI 48.6K
- XBIT 60.1K
- Earning Date
- UFI 10-29-2025
- XBIT 11-12-2025
- Dividend Yield
- UFI N/A
- XBIT N/A
- EPS Growth
- UFI N/A
- XBIT N/A
- EPS
- UFI N/A
- XBIT N/A
- Revenue
- UFI $571,344,000.00
- XBIT N/A
- Revenue This Year
- UFI $9.98
- XBIT N/A
- Revenue Next Year
- UFI $5.75
- XBIT N/A
- P/E Ratio
- UFI N/A
- XBIT N/A
- Revenue Growth
- UFI N/A
- XBIT N/A
- 52 Week Low
- UFI $4.25
- XBIT $2.50
- 52 Week High
- UFI $7.55
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- UFI 55.23
- XBIT 35.75
- Support Level
- UFI $4.27
- XBIT $2.62
- Resistance Level
- UFI $4.78
- XBIT $2.73
- Average True Range (ATR)
- UFI 0.16
- XBIT 0.10
- MACD
- UFI 0.00
- XBIT -0.00
- Stochastic Oscillator
- UFI 84.91
- XBIT 8.10
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.